| Shareholder | |||
|---|---|---|---|
| Qu JiguangExecutive Director | 43.46% | 1.28B | |
| 四川科倫藥業股份有限公司 | 23.07% | 680.69M | |
| 四川科倫藥業股份有限公司 | 18.05% | 512.62M | |
| UBS Group AG | 5.59% | 164.97M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| China Pharmaceutical Company Limited | 500.00K | 2.77 | Voluntary disclosure | 925.20M | 31.35% | ||
| China Pharmaceutical Company Limited | 1.50M | 2.78 | Voluntary disclosure | 924.70M | 31.33% | ||
| China Pharmaceutical Company Limited | 500.00K | 2.77 | Voluntary disclosure | 923.20M | 31.28% | ||
| China Pharmaceutical Company Limited | 1.25M | 2.80 | Voluntary disclosure | 922.70M | 31.26% | ||
| China Pharmaceutical Company Limited | 1.15M | 2.73 | Voluntary disclosure | 921.45M | 31.22% | ||
| China Pharmaceutical Company Limited | 1.40M | 2.77 | Voluntary disclosure | 920.30M | 31.18% | ||
| UBS Group AG | 577.49K | -- | Borrowed shares returned (short) | 29.04M | 0.98% | ||
| China Pharmaceutical Company Limited | 1.40M | 2.69 | Voluntary disclosure | 918.90M | 31.13% | ||
| China Pharmaceutical Company Limited | 1.00M | 2.62 | Voluntary disclosure | 917.50M | 31.09% | ||
| China Pharmaceutical Company Limited | 870.00K | 2.62 | Voluntary disclosure | 916.50M | 31.05% | ||
| China Pharmaceutical Company Limited | +880.00K | 2.73 | Bought | 915.63M | 31.02% | ||
| China Pharmaceutical Company Limited | 1.30M | 2.71 | Voluntary disclosure | 914.75M | 30.99% | ||
| China Pharmaceutical Company Limited | 1.00M | 2.74 | Voluntary disclosure | 913.45M | 30.95% | ||
| China Pharmaceutical Company Limited | 850.00K | 2.75 | Voluntary disclosure | 912.45M | 30.91% | ||
| UBS Group AG | 4.57M | -- | Other event | 172.63M | 5.85% | ||
| UBS Group AG | 5.28M | -- | Other event | 181.88M | 6.16% |
This page shows the major shareholders of SSY GROUP (02005) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

